UK Explains Dos and Don’ts Of Adaptive Clinical Trials
Dose Escalation Poses Particular Challenges
Executive Summary
Adaptive clinical trials offer several benefits, but they require effective management to be successful, says a senior inspector at the UK’s medicines regulator.
You may also be interested in...
UK MHRA Finds Labs Releasing Unreliable Data Due To Pressure From Pharma
A UK regulator with the MHRA is concerned that bioanalytical laboratories are not being given enough time to do their job properly by drug companies under pressure to ensure their clinical trials remain on schedule.
COVID-19 Vaccines Donated To Philippines Require Emergency Use Authorization
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
EDQM Sets 2023 Target For Modernizing ‘Certificates Of Suitability’
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: